In February 2010, aztreonam for inhalation solution (Cayston; Gilead) — an inhalable formulation of the monobactam antibiotic aztreonam and lysine — was approved by the US FDA to improve ...

Part B medication coverage is limited to drugs administered through durable medical equipment, including nebulizers and compressors, and medications that are available as inhalation solutions.

The partnership underscores Greentank and AIR's shared commitment to creating safer and more sophisticated inhalation solutions, making a meaningful impact on how consumers experience and benefit from ...

The partnership underscores Greentank and AIR's shared commitment to creating safer and more sophisticated inhalation solutions, making a meaningful impact on how consumers experience and benefit ...

Our lead program, molgramostim inhalation solution, is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar ...